Stay updated on Nivolumab and Ipilimumab in ACC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in ACC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Minor formatting tweaks and updates to non-critical metadata were observed, and core study details such as title, NCT number, objectives, eligibility criteria, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:52:53.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    2%
    Check dated 2025-10-06T04:25:23.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Expanded immune biology content and updated version to v3.1.0, replacing the previous v3.0.2.
    Difference
    0.7%
    Check dated 2025-09-29T00:58:11.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows revision v3.0.2, upgrading from v3.0.1. The 'Back to Top' link was removed, a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-14T18:44:00.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T13:10:59.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has added significant content related to Salivary Gland Cancer, including a study on treatment options and various related medical topics, while removing several previous references to oral cancer and related diseases.
    Difference
    4%
    Check dated 2025-08-31T05:37:20.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in ACC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.